Heterozygous MAP3K20 variants cause ectodermal dysplasia, craniosynostosis, sensorineural hearing loss, and limb...

Area of Science:

• Genetics
• Developmental Biology
• Molecular Biology

Background:

• Biallelic pathogenic variants in MAP3K20 are linked to specific congenital disorders.
• Heterozygous variants in MAP3K20 have not been clearly associated with a distinct phenotype.
• MAP3K20 encodes a mitogen-activated protein kinase involved in cellular signaling pathways.

Purpose of the Study:

• To characterize the phenotypic spectrum associated with heterozygous de novo variants in the MAP3K20 gene.
• To investigate the role of MAP3K20 in human development, particularly in relation to specific congenital anomalies.
• To establish genotype-phenotype correlations for novel variants in MAP3K20.

Main Methods:

• Clinical evaluation of five individuals with de novo heterozygous variants in MAP3K20.
• Genetic sequencing to identify variants in the MAP3K20 gene.
• Analysis of clinical features including craniosynostosis, limb anomalies, hearing loss, and ectodermal dysplasia-like phenotypes.

Main Results:

• Five individuals with heterozygous de novo variants in the MAP3K20 linker region presented with diverse clinical features.
• Observed phenotypes included craniosynostosis, limb anomalies, sensorineural hearing loss, and ectodermal dysplasia-like features.
• The identified variants were located in a specific region between the kinase and leucine zipper domains of MAP3K20.

Conclusions:

• Heterozygous de novo variants in MAP3K20 define a novel spectrum of developmental disorders.
• The findings expand the known phenotypic spectrum associated with MAP3K20.
• MAP3K20's role in endothelial-mesenchymal transition may underlie the observed congenital anomalies.